Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 395
Selected: 0
NCT IDTitle
NCT02263898Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations
NCT00138164Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00234000Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
NCT06216249Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
NCT02092948Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer
NCT00040950Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00006084Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
NCT00033514Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression
NCT04069923OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
NCT03996850SPECT/CT for the Characterization of Renal Masses
NCT03623854Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
NCT00761124Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
NCT00084747Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
NCT00039325Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
NCT07323641Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
NCT00612066Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
NCT04429204Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma
NCT00460200Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
NCT00020865Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
NCT00004865Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
NCT04624256Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
NCT07077239Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
NCT06432036Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
NCT07242365Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy
NCT00045318Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
NCT00345826Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
NCT07461948Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
NCT00040989BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
NCT00742729Increasing Colorectal Cancer Screening Among Filipino Americans
NCT00344799Cytogenetic Study of Ocular Melanoma
NCT00004114Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
NCT00093730BMS-599626 in Treating Patients With Metastatic Solid Tumors
NCT00335751PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
NCT00427427Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
NCT06090903Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
NCT00054574Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
NCT00042913Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
NCT03830918Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
NCT06090916Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer
NCT00646633Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
NCT00047255Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
NCT01873248Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
NCT00998010Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT00060294Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
NCT04457245Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT03582475Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
NCT04473781Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
NCT04007029Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
NCT03411070SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer
NCT00949819Active Surveillance for Cancer of the Prostate (ASCaP)